Current Report Filing (8-k)
October 24 2016 - 7:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 24, 2016
FORTRESS BIOTECH, INC.
(Exact Name of Registrant
as Specified in Charter)
Delaware
|
001-35366
|
20-5157386
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
2 Gansevoort Street, 9th Floor, New York, New York
|
10014
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s Telephone Number, Including
Area Code:
(781) 652-4500
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Attached hereto as Exhibit 99.1 and incorporated
herein by reference is a presentation including a further updated corporate overview of Fortress Biotech, Inc.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
Exhibit
No.
|
Description
|
|
|
99.1
|
Presentation of October 2016.
|
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
|
FORTRESS BIOTECH, INC.
|
|
|
|
|
|
Date: October 24, 2016
|
|
|
|
|
/s/
Lindsay A. Rosenwald
|
|
|
Name:
|
Lindsay A. Rosenwald, M.D.
|
|
|
Title:
|
Chairman of the Board of Directors,
President and Chief Executive Officer
|
|
Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From Apr 2024 to May 2024
Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From May 2023 to May 2024